NASDAQ:BMRN - BioMarin Pharmaceutical Price Target & Analyst Ratings

+1.91 (+2.50 %)
(As of 08/21/2019 10:37 AM ET)
Today's Range
Now: $78.42
50-Day Range
MA: $79.74
52-Week Range
Now: $78.42
Volume11,726 shs
Average Volume1.26 million shs
Market Capitalization$14.07 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
14 Wall Street analysts have issued ratings and price targets for BioMarin Pharmaceutical in the last 12 months. Their average twelve-month price target is $115.60, suggesting that the stock has a possible upside of 47.41%. The high price target for BMRN is $133.00 and the low price target for BMRN is $81.00. There are currently 3 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.792.812.822.70
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $115.60$115.5385$116.00$113.9506
Price Target Upside: 47.41% upside38.99% upside34.17% upside29.36% upside

BioMarin Pharmaceutical (NASDAQ:BMRN) Consensus Price Target History

BioMarin Pharmaceutical (NASDAQ:BMRN) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/5/2019JPMorgan Chase & Co.Reiterated RatingBuy$133.00HighView Rating Details
7/10/2019WedbushReiterated RatingOutperform$128.00MediumView Rating Details
5/23/2019CitigroupReiterated RatingBuy ➝ BuyLowView Rating Details
4/26/2019Robert W. BairdSet Price TargetBuy$120.00LowView Rating Details
4/26/2019Cantor FitzgeraldReiterated RatingBuy$131.00LowView Rating Details
4/9/2019Raymond JamesInitiated CoverageOutperform ➝ Outperform$110.00LowView Rating Details
2/25/2019SunTrust BanksLower Price TargetBuy$117.00MediumView Rating Details
2/24/2019BarclaysReiterated RatingHold$95.00HighView Rating Details
2/22/2019OppenheimerLower Price Target$92.00 ➝ $81.00MediumView Rating Details
1/7/2019CowenReiterated RatingBuyMediumView Rating Details
12/17/2018GuggenheimInitiated CoverageNeutralHighView Rating Details
12/14/2018Wolfe ResearchInitiated CoverageOutperform ➝ OutperformMediumView Rating Details
10/23/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$113.00 ➝ $116.00LowView Rating Details
10/16/2018Jefferies Financial GroupBoost Price TargetFair Value ➝ Buy$125.00HighView Rating Details
8/3/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$113.00 ➝ $115.00HighView Rating Details
8/3/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$102.00 ➝ $109.00HighView Rating Details
7/9/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$120.00 ➝ $122.00LowView Rating Details
5/7/2018Leerink SwannBoost Price TargetOutperform$132.00 ➝ $145.00MediumView Rating Details
4/30/2018Sanford C. BernsteinLower Price TargetMarket Perform$97.00 ➝ $92.00MediumView Rating Details
2/27/2018Royal Bank of CanadaReiterated RatingHold$94.00MediumView Rating Details
2/23/2018BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$119.00 ➝ $125.00HighView Rating Details
2/23/2018Deutsche BankSet Price TargetBuy ➝ Buy$119.00 ➝ $124.00HighView Rating Details
1/18/2018Piper Jaffray CompaniesReiterated RatingBuy$114.00LowView Rating Details
12/15/2017Goldman Sachs GroupUpgradeBuy ➝ Conviction-BuyHighView Rating Details
(Data available from 8/21/2017 forward)
This page was last updated on 8/21/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel